Tracking XFLH? Get live short interest, options flow, and signals on ORTEX.Sign up free →

XFLH

XFLH Capital Corporation

NYSE

Renogen Biolab Inc. signed a letter of intent on September 22, 2026, to acquire XFLH Capital Corporation (NYSE: XFLH) through a reverse merger. In this structure, a private company — here, Renogen Biolab — absorbs a publicly listed shell to gain a stock-market listing without a traditional IPO. The letter of intent is a preliminary agreement only; no completed transaction has been announced. For…

$10.09-7.26% 1d+0.20% 1w+0.90% 1mClose: 16 Oct 2026

Short interest % of float: Dropping
Cost to borrow: Dropping
Availability: High

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Snapshot as of 19 Oct 2026

Articles

XFLH

XFLH Capital targeted in reverse merger with Renogen Biolab

23 Sept 2026, 13:301 min read

Want the live picture for XFLH?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for XFLH — free to start on ORTEX.